Wastage of Health Resources during COVID-19 in Iran: Lessons for Health Policy and Management

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Effective management of health resources during crises, such as pandemics, is crucial for preventing waste and ensuring system efficiency. This study assessed the extent of wastage of COVID-19 vaccines, diagnostic kits, and pharmaceutical products in Iran during the pandemic and examined the implications for health policy. Methods: A descriptive, quantitative design was used, analyzing national-level data from 50 medical universities across Iran between 2021 and 2023. Distribution, utilization, and wastage data were extracted from Ministry of Health databases. A bottom-up costing approach was used to estimate the financial burden of these losses. Results: Of over 145 million COVID-19 vaccine doses distributed, 18.3% were wasted. Additionally, 21.1% of medications and 29.5% of diagnostic kits were discarded due to expiration or non-utilization. Key factors contributing to wastage included poor inventory management, frequent revisions of clinical protocols, and reduced demand in later pandemic stages. Conclusion: The findings highlight structural inefficiencies in health resource management and emphasize the need for reforms, including real-time monitoring systems and improved cross-sectoral coordination to reduce waste and enhance future preparedness.

Article activity feed